COVID-19
COVID-19 frontline

HIV medication beneficial to some patients

cgtn.com | Updated: 2020-04-26 17:00

Doctors from the China-Japan Friendship Hospital in Beijing shared their first-hand working experience in Wuhan with their counterparts from Thailand, through a video conference on Thursday. Professor Cao Bin, vice-president of the Beijing hospital, shared his clinical trial on Lopinavir–Ritonavir, a combination of HIV antiviral drugs, saying it is a positive experiment with Lopinavir–Ritonavir shown effective results on certain groups of people.

Please feel free to contact us by sending your questions to question@chinadaily.com.cn or commenting on China Daily app. We will ask experts to answer them.

Editor's picks
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US